Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 285,423 | 172,870 | 115,156 | 100,886 | 80,154 |
| Operating Income | -285,423 | -172,870 | -115,156 | -100,886 | -80,154 |
| Interest Expense | 4,668 | 3,099 | 739 | 0 | 0 |
| Other Income | 38,031 | 24,210 | 3,862 | 109 | 947 |
| Pre-tax Income | -252,060 | -151,759 | -112,033 | -100,777 | -79,207 |
| Net Income Continuous | -252,060 | -151,759 | -112,033 | -100,777 | -79,207 |
| Net Income | $-252,060 | $-151,759 | $-112,033 | $-100,777 | $-79,207 |
| EPS Basic Total Ops | -3.75 | -2.89 | -2.87 | -2.89 | -2.52 |
| EPS Basic Continuous Ops | -3.75 | -2.89 | -2.87 | -2.89 | -2.52 |
| EPS Diluted Total Ops | -3.75 | -2.89 | -2.87 | -2.89 | -2.52 |
| EPS Diluted Continuous Ops | -3.75 | -2.89 | -2.87 | -2.89 | -2.52 |
| EPS Diluted Before Non-Recurring Items | -3.75 | -2.89 | -2.87 | -2.89 | -2.52 |
| EBITDA(a) | $-297,916 | $-181,947 | $-114,921 | $-99,779 | $-80,054 |